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ABSTRACT
A cloned 5248-bp EcoRI fragment from the Kleb-
siella pneumoniae transferable plasmid pKP53
(> 70 kb) containing blaSHV-5 was sequenced.
Insertion sequences IS26 and IS5 were found
downstream from blaSHV-5. The DNA sequences
of the genetic environment surrounding blaSHV-5
were homologous to plasmid p1658 ⁄ 97 from
Escherichia coli, containing a truncated recF gene
and a truncated deoR gene upstream and down-
stream from blaSHV-5, respectively. RecF may be
involved in blaSHV-5 translocation to the plasmid
by RecF-dependent recombination. This novel
genetic environment may be associated with the
successful proliferation and ⁄ or expression of
SHV-5 in K. pneumoniae strains from Taiwan.
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Extended-spectrum b-lactamases (ESBLs), such as
TEM, SHV and CTX-M types, are common in
Klebsiella pneumoniae, where they confer resistance
to broad-spectrum b-lactams [1,2]. Despite an
increasing incidence of ESBLs worldwide, infor-
mation concerning the mobilisation of ESBL genes
remains scarce [2,3]. Mobile blaSHV-5 and blaSHV-2a
genes may have evolved from a chromosomally
located blaSHV-1 gene following IS26-dependent
mobilisation [3]. In addition to transfer of ESBL
genes by conjugative plasmids [2], insertion
sequence ISEcp1 and a sul1-type class 1 integron
have been implicated in the spread of blaCTX-M
[4,5].
In Taiwan, SHV-5 represents about 60% of all
ESBLs produced by K. pneumoniae isolates [6].
Although plasmid dissemination and clonal
spread may contribute to proliferation of ESBLs,
most SHV-5 producers with different plasmid
profiles are clonally unrelated [6,7]. It is not easy
to explain why SHV-5 predominates among these
sporadic isolates. Although blaSHV-5 has been
found 5¢ to an integron that contains aminogly-
coside resistance determinants on plasmids such
as pACM1 from Klebsiella oxytoca [8], pSEM from
Salmonella enterica serotype Typhimurium [9], and
p1658 ⁄ 97 from Escherichia coli (accession no.
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AF550679), evidence for direct carriage of blaSHV-5
by an integron has not been found. Therefore, the
present study sequenced the genetic environment
surrounding blaSHV-5 from a K. pneumoniae isolate
in order to investigate its possible means of
mobilisation among plasmids.
Four K. pneumoniae isolates with the same
EcoRI-digested plasmid profile were selected
from among 24 SHV-5-producers identified pre-
viously [10]. The following cloning experiments
were successful with only one of the isolates,
K. pneumoniae KP53, isolated from a catheter-tip.
MICs were determined by agar dilution and the
ESBL phenotype was confirmed by a reduction of
> 3 log2 dilutions in the MICs of either ceftazidime
or cefotaxime in the presence of clavulanic acid
4 mg ⁄L [11].
Escherichia coli J53-2 (rifampicin-resistant) was
used as the recipient in conjugation experiments.
Transconjugants were selected on trypticase soy
agar plates supplemented with rifampicin
100 mg ⁄L and cefotaxime 2 mg ⁄L. Plasmid
DNA was extracted using a rapid alkaline lysis
method [12]. Analytical isoelectric focusing (IEF)
was performed on ampholine-polyacrylamide
gels, and b-lactamase bands were visualised by
overlaying with nitrocefin 0.2 g ⁄L [13]. Known
isoelectric point (pI) standards used for compar-
ison included TEM-1 (pI 5.4), TEM-4 (pI 5.9),
SHV-3 (pI 7.0), SHV-1 (pI 7.6), SHV-4 (pI 7.8) and
SHV-5 (pI 8.2).
PCRs, endonuclease digestions, ligation, elec-
troporation, transformation, agarose gel electro-
phoresis and molecular cloning were performed
as described previously [6,7,9]. The PCR primers
used were S1 (5¢-TGGTTATGCGTTATATTCGCC)
and S2 (5¢-GGTTAGCGTTGCCAGTGC) for
blaSHV, and P1 (5¢-CGGATGAAGGCAACCCA)
and P2 (5¢-AAGCAGACTTGACCTGATAGT) for
the conserved 5¢-CS to 3¢-CS region of class 1
integrons. DNA sequencing was performed on an
automated ABI 377 DNA sequencer (Applied
Biosystems, Foster City, CA, USA).
Plasmid pOK12 and E. coli DH5a were used in
the cloning experiments [9]. K. pneumoniae KP53
harboured a > 70-kb transferable plasmid, pKP53.
Following conjugation, the DNA fragments of
EcoRI-digested pKP53 from the J53-2 E. coli
transconjugant were cloned into the EcoRI site of
EcoRI-digested pOK12. The resulting plasmid
(pKP6) was then electroporated into E. coli
DH5a. Electroporants containing recombinant
plasmids were selected on trypticase soy agar
containing cefotaxime 2 mg ⁄L.
MICs for KP53 were: cefotaxime 256 mg ⁄L,
ceftazidime 256 mg ⁄L, cefoxitin 2 mg ⁄L, cefepime
2 mg ⁄L and imipenem 0.25 mg ⁄L. The MICs of
cefotaxime ⁄ clavulanate and ceftazidime ⁄ clavula-
nate for KP53 were 0.12 mg ⁄L and < 0.03 mg ⁄L,
respectively. E. coli J53-2 (pKP53) and E. coli DH5a
(pKP6) displayed similar drug susceptibility pro-
files, confirming the ESBL phenotype.
IEF of crude extracts from KP53, J53-2 (pKP53)
and DH5a (pKP6) revealed b-lactamases with pIs
of 8.2, 7.6 and 5.4; 8.2 and 5.4; and 8.2, respect-
ively. The non-transferable b-lactamase with a pI
of 7.6 was presumed to be a chromosomal SHV-1
b-lactamase in KP53. The transferable b-lactamas-
es with pIs of 8.2 and 5.4 were matched to SHV-5
and TEM-1, respectively.
Sequencing of the cloned EcoRI fragment from
pKP6 revealed a 5248-bp insert, with an 861-bp
open reading frame encoding a deduced protein
identified as SHV-5 (Fig. 1). The promoter se-
quences of blaSHV-5 corresponded exactly to those
of previously identified blaSHV-1, blaSHV-2 and
blaSHV-5 genes, suggesting the conservation of
blaSHV promoters [14]. In addition, the DNA
sequences upstream from blaSHV-5 revealed a RecF
gene and a non-coding region that was 99%
identical to parts of plasmids p1658 ⁄ 97, pSEM
and pSF2 [15] (Fig. 2), indicating a close evolu-
tionary relationship among the recF genes of these
plasmids. Although the function of this RecF gene
remains uncertain, it may contribute to bla gene
mobilisation to a plasmid via the RecF recombi-
nation pathway [16].
The blaSHV-5 gene in pKP6 preceded a truncated
deoR (DEOR transcriptional regulator protein), an
IS26 element and an IS5 element. The deoR gene is
Fig. 1. Schematic map showing the EcoRI fragment from
recombinant plasmid pKP6 which contains blaSHV5. The
end of IS5 is underlined and shown in lower case, while
the consensus target sequences (YATR) of the IS5 insertion
are shown in bold.
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also present in the corresponding region of
plasmids p1658 ⁄ 97 (accession no. AF550679) and
pSEM (accession no. AJ245670). Both insertion
sequences contained the appropriate transposase
gene and inverted repeats. The IS26 element was
identical to that flanking blaSHV-2a in plasmids
pPL-20 from Pseudomonas aeruginosa [17] and
pZMP1 from K. pneumoniae [18], as well as that
associated with blaSHV5 in plasmids pSEM,
p1658 ⁄ 97 and pACM1 [19]. However, the direc-
tion and distance separating IS26 from blaSHV
differs in these plasmids (Fig. 2): in pKP6, IS26 is
located 377 bp downstream from blaSHV-5; in
pSEM, p1658 ⁄ 97 and pACM1, a first copy of
IS26 is located c.2.6 kb upstream from blaSHV-5,
with an additional copy downstream; and in pPL-
20 and pZMP1, IS26 closely precedes the ATG
codon of blaSHV-2a, and might function as a
promoter. IS26 has been regarded as a promoter
for the expression of an aminoglycoside resistance
gene [20], and a similar hybrid promoter is
responsible for high-level expression of TEM-6
and SHV-2a [15,21].
IS5 is a 1195-bp mobile DNA element found in
the genome of various E. coli K-12 strains, where
it mediates chromosomal rearrangements [22].
This suggests a possible enterobacterial origin of
IS5 for the K. pneumoniae isolate studied. There is
evidence that homologous recombination of IS5
and sur (sulphathiazole-resistant gene) could
account for amplification of the sur gene and
over-expression of dihydropteroate synthetase,
thereby conferring high-level resistance to sul-
phathiazole in E. coli [23]. However, the precise
role of IS5 in the K. pneumoniae isolate remains
unclear. This is the first description of IS5 linked
closely to blaSHV-5 on a K. pneumoniae plasmid.
The presence of two tnpA-containing IS elements
(IS26 and IS5) and a recF sequence linked closely
to blaSHV-5 indicates that its translocation to
pKP53 may have occurred by homologous
recombination, rearrangements or transposon-
mediated mobilisation.
PCR experiments with pKP53 DNA as template
failed to link blaSHV-5 to a class-1 integron,
although integrons containing trimethoprim and
aminoglycoside resistance genes (dhfrXII and
aadA2, respectively) were identified.
In conclusion, two insertion sequences, IS26
and IS5, linked closely to blaSHV-5 on a K. pneu-
moniae transferable plasmid, were identified, sug-
gesting transposon involvement in the assembly
of antibiotic resistance islands by gene mobilisa-
tion. Together with RecF, these genetic elements
may contribute to the extensive proliferation of
SHV-5 among klebsiellae in Taiwan. Further
experiments are required to investigate the pre-
valence of this novel genetic environment among
SHV-producing Enterobacteriaceae.
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ABSTRACT
Neisseria gonorrhoeae is the most common sexually
transmitted disease-causing bacterium world-
wide. An in-house PCR assay targeting the
carbamoyl-phosphate synthase subunit A (carA)
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